176 / 1068
Conclusions (I)
What have we learned?
•
Sequence RT, Chemo, S matters
(CAO/ARO/AIO-94)
•
Synergy RT – 5-FU Chemo
(FFCD 9303, EORTC 22921)
•
RT - optimized S complementary
(Dutch Trial, MRC CR07)
•
Interval between RT + S matters
(TIMING; Stockholm III)
•
Compliance RT + Chemo matters
(CAO/ARO/AIO-04)